Mergers & Acquisitions ·
Organigram agrees to acquire Aurora Cannabis for C$7.80 cash or stock in expected January 2027 deal
ACBAurora Cannabis Inc
Aurora Cannabis announced its fiscal 2027 second quarter results, reporting net revenue of $86.0 million and adjusted EBITDA of $14.0 million. Concurrently, the company disclosed that it has entered into a definitive agreement for Organigram Global Inc. to acquire all outstanding Aurora shares in exchange for C$7.80 cash, 5.8626 Organigram common shares, or a combination thereof. The transaction is structured as a statutory plan of arrangement and is expected to close in January 2027, pending shareholder, court, and regulatory approvals. A special meeting to vote on the deal is scheduled for December 2026. Aurora Cannabis Inc. operates as a global medical cannabis company with manufacturing facilities in Canada and Germany.